click below
click below
Normal Size Small Size show me how
Adult Health Nursing
Ch 4 pharm MEL
Question | Answer | Answer | Answer | Answer | Answer |
---|---|---|---|---|---|
Vitamin D - dihydroxy | 6 - 52 | ||||
Alkaline phosphatase | 30 - 120 | ||||
Erythrocyte sedimentation rate (ESR) | M = up to 15 W = up to 20 | ||||
Lupus Erythematous (LE) | No LE cells seen | ||||
Rheumatoid factor (RF) | <60 units per ML | ||||
Uric acid (blood) | M = 2.1 - 8.5 W = 2.0 - 6.6 | ||||
Salicylates | Aspirin, salicylate | Anti-inflammatory, analgesic, antipyretic, act by inhibiting synthesis of prostaglandins | Prolonged bleeding, Tinnitus, dizziness with repeated large doses, exacerbation of asthma, G.I. irritation(dyspepsia, nausea, ulcer, hemorrhage) | RA | |
NSAIDs | Indomethacin/Indocin | Analgesic, anti-inflammatory | Headache, vertigo, insomnia; confusion, G.I. irritation, can decrease the effects of ACE inhibitors | RA | |
NSAIDs | Ibuprofen/Motrin: Advil | Analgesic, anti-inflammatory | Headache, vertigo, insomnia; confusion, less irritating to G.I. tract, fluid retention, can cause hypertension | RA | |
NSAIDs | Naproxen/naprosyn | Analgesic, anti-inflammatory | Same as ibuprofen, also causes drowsiness | RA | |
COX-2 inhibitors | Celebrex/celecoxib | Analgesic, anti-inflammatory | Mild to moderate indigestion, risk of G.I. bleeding, diarrhea, abdominal pain monitor for MI or stroke | RA | |
Potent anti-inflammatory agents | Adrenocortical steroids/prednisone | Interferes with bodies normal inflammatory responses | Increases BP, fluid retention, osteoporosis, adrenal insufficiency, moon face, increased blood sugar in diabetics, slow wound healing, and Na retention, K + depletion,hypertension | RA | |
Antineoplastic | Trexall: Folex: Rheumatrex/methotrexate | Alters the way the body uses fully acid, which is necessary for cell growth; decreases inflammation | Upset stomach, N&V, anorexia, diarrhea, sore mouth; headache, blurred vision, dizziness | RA | |
DMARDs= Disease modifying anti-rheumatoid drugs | Enbrel/Etanercept subQ | Blocks the normal in inflammatory immune responses seen in RA; binds TNF: which is involved in immune and inflammatory reactions | Pain at injection site, upper respiratory tract infections and sinusitis; in severe cases of tuberculosis possible | RA | |
DMARDs= disease modifying anti-rheumatoid drugs | Infliximab/Remicade IV | Anti-body that bind specifically to pro-inflammatory enzymes that are produced by the synovial cells | Upper respiratory tract infections, headache, nausea, sinusitis, rash, cost | RA | |
DMARDs = disease modifying anti-rheumatoid drugs | Humira/Adalimumab | Reduces infiltration of inflammatory cells can increased risk of infection, headaches and rash; neutropenia; injection site reaction | Assess for signs of infection before injection, do not give to patients with active injections, monitor new infections closely | RA | |
Osteoporosis | Biophosphates | Fosamax, Alendronate | Slow bone loss and increase bone density | Difficulty in swallowing, chest pain, severe or recurring heartburn | Pill, sitting upright, @least 30 minutes before other meds |
Calcium | 9.0 - 10.5 | ||||
Phosphorus | 2.5 - 4.5 |